Frontlight ResearchEarly access
Acute myeloid leukaemia trials in United States
334 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleChemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
- Where
- Seattle
- Age
- 18 years and over
- People
- 36
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT06928662 - Phase 1Taking peopleSNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation
- Where
- Chapel Hill, Columbus, Madison, Philadelphia
- Age
- 18 years and over
- People
- 30
- Run by
- Uma Borate
See details and how to joinNCT06222580 - Phase 2Taking peopleCord Blood Transplantation in Children and Young Adults With Blood Cancer
- Where
- New York
- Age
- Up to 26 years
- People
- 71
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07566377 - No phaseTaking peopleMCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
- Where
- Milwaukee
- Age
- 0 years to 25 years
- People
- 40
- Run by
- Medical College of Wisconsin
See details and how to joinNCT05794880 - Phase 1Not yet taking people in United StatesBSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation
- Where
- Duarte
- Age
- 18 years and over
- People
- 19
- Run by
- City of Hope Medical Center
See details and how to joinNCT07583303 - Phase 1Taking peoplePhase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS
- Where
- Charlottesville
- Age
- 18 years and over
- People
- 23
- Run by
- University of Virginia
See details and how to joinNCT07270978 - No phaseTaking peopleStudy of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
- Where
- Boston, Brighton, Kalamazoo, Londonderry, Methuen, Milford, Weymouth
- Age
- 18 years and over
- People
- 10,000
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT02269592 - Phase 1Taking peopleStudy of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- Where
- Boston, Chapel Hill, Chicago, Cincinnati, Columbus, Houston, Salt Lake City
- Age
- 13 years and over
- People
- 100
- Run by
- Newave Pharmaceutical Inc
See details and how to joinNCT04771572 - Phase 2Taking peopleCardioprotection in AML
- Where
- Charlottesville
- Age
- 18 years and over
- People
- 70
- Run by
- University of Virginia
See details and how to joinNCT04977180 - Phase 1Taking peopleAdoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML
- Where
- Boston
- People
- 30
- Run by
- David Avigan
See details and how to joinNCT07374029 - Phase 1Taking peoplePilot Imaging Study of Leukemia
- Where
- Atlanta, Oklahoma City, Washington D.C.
- Age
- 4 years to 80 years
- People
- 60
- Run by
- University of Oklahoma
See details and how to joinNCT03633955 - Phase 1Taking peopleStudy of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
- Where
- Cincinnati, Duarte, Hershey, Little Rock, Madison, Memphis, Phoenix, Salt Lake City, Stanford
- Age
- Up to 21 years
- People
- 34
- Run by
- Norman J. Lacayo
See details and how to joinNCT05101551 - Phase 1Taking peopleImetelstat Combinations in Relapsed AML
- Where
- New York
- Age
- 18 years and over
- People
- 36
- Run by
- Douglas Tremblay
See details and how to joinNCT07320235 - Phase 2Taking peopleOlutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy
- Where
- Miami
- Age
- 18 years to 75 years
- People
- 16
- Run by
- Justin Watts, MD
See details and how to joinNCT06782542 - Phase 2Taking peopleMT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
- Where
- Minneapolis
- Age
- 2 years to 75 years
- People
- 132
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT07493538 - Phase 1/2Taking peoplePhase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
- Where
- Philadelphia
- Age
- 1 month to 25 years
- People
- 100
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT06839456 - No phaseTaking peopleMassage Impact on Sleep in Pediatric Oncology
- Where
- Philadelphia, Washington D.C.
- Age
- 12 years to 21 years
- People
- 70
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT06892158 - Phase 1/2Taking peopleTagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML
- Where
- Palo Alto
- Age
- 18 years and over
- People
- 20
- Run by
- Stanford University
See details and how to joinNCT06561152 - No phaseTaking peopleThe Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
- Where
- Winston-Salem
- Age
- 18 years to 120 years
- People
- 2,000
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT01890486 - Phase 1/2Taking peopleA Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
- Where
- Charlottesville, Chicago, Houston, Jacksonville, Phoenix, Rochester, Seattle
- Age
- 18 years and over
- People
- 225
- Run by
- Chordia Therapeutics, Inc.
See details and how to joinNCT05732103 - Phase 1Taking peopleA Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
- Where
- Buffalo, Duarte, Houston, Irvine, Kansas City, Merriam, New York
- Age
- 18 years and over
- People
- 48
- Run by
- GluBio Therapeutics Inc.
See details and how to joinNCT06146257 - No phaseTaking peopleBacktracking Leukemia-Typical Somatic Mutations in Cord Blood
- Where
- Minneapolis
- Age
- Up to 25 years
- People
- 300
- Run by
- Children's Oncology Group
See details and how to joinNCT05014165 - Phase 2Taking peopleMT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
- Where
- Minneapolis
- Age
- Up to 60 years
- People
- 70
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT05735717 - Phase 2Taking peopleBCL2i CLAG-M in R/R Acute Myeloid Leukemia
- Where
- Boston, Tampa
- Age
- 18 years to 80 years
- People
- 52
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06660368 - Phase 1Taking peopleExpanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
- Where
- Columbus, Westwood
- Age
- 18 years to 65 years
- People
- 38
- Run by
- University of Kansas Medical Center
See details and how to joinNCT03533816